|
9471 |
The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan
Enthalten in Trials Bd. 21, 26.8.2020, Nr. 1, date:12.2020: 1-19
|
|
|
|
9472 |
The Pericapsular Nerve Group (PENG) block combined with Local Infiltration Analgesia (LIA) compared to placebo and LIA in hip arthroplasty surgery: a multi-center double-blinded randomized-controlled trial
Enthalten in BMC anesthesiology Bd. 22, 6.8.2022, Nr. 1, date:12.2022: 1-9
|
|
|
|
9473 |
The placebo effect in the motor domain is differently modulated by the external and internal focus of attention
Enthalten in Scientific reports Bd. 8, 16.8.2018, Nr. 1, date:12.2018: 1-14
|
|
|
|
9474 |
The placebo effect shortens movement time in goal-directed movements
Enthalten in Scientific reports Bd. 12, 15.11.2022, Nr. 1, date:12.2022: 1-12
|
|
|
|
9475 |
The Powerful Placebo Effect in Cough: Relevance to Treatment and Clinical Trials
Enthalten in Lung Bd. 198, 13.12.2019, Nr. 1, date:2.2020: 13-21
|
|
|
|
9476 |
The PRAISE study: A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of iloprost in the early postoperative period after liver transplantation (ISRCTN12622749)
Enthalten in BMC surgery Bd. 13, 29.1.2013, Nr. 1, date:12.2013: 1-8
|
|
|
|
9477 |
The prebiotic effects of soluble dietary fiber mixture on renal anemia and the gut microbiota in end-stage renal disease patients on maintenance hemodialysis: a prospective, randomized, placebo-controlled study
Enthalten in Journal of translational medicine Bd. 20, 14.12.2022, Nr. 1, date:12.2022: 1-13
|
|
|
|
9478 |
The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease
Enthalten in Pilot and feasibility studies Bd. 9, 8.5.2023, Nr. 1, date:12.2023: 1-10
|
|
|
|
9479 |
The PROMOTe study: targeting the gut microbiome with prebiotics to overcome age-related anabolic resistance: protocol for a double-blinded, randomised, placebo-controlled trial
Enthalten in BMC geriatrics Bd. 21, 1.7.2021, Nr. 1, date:12.2021: 1-10
|
|
|
|
9480 |
The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate
Enthalten in Trials Bd. 26, 29.1.2025, Nr. 1, date:12.2025: 1-12
|
|
Administration
